SCHEMBL20788693

SCHEMBL20788693

CC(=O)c1ccc(NC(=O)c2ccc(NC(=O)C(CC(N)=O)NC(=O)c3ccc(NC(=O)c4ccc(C)cc4)cc3)cc2)c(OC(C)C)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ HDAC8 Q9BY41 3/20 0.39
▸ HDAC3 O15379 2/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC7 Q8WUI4 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ HDAC10 Q969S8 2/20 0.39
▸ HDAC11 Q96DB2 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ HDAC9 Q9UKV0 2/20 0.39
▸ HDAC5 Q9UQL6 2/20 0.39
▸ PLAU P00749 3/20 0.38
▸ HPN P05981 2/20 0.38
▸ HTT P42858 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20787628 0.94 MEN1 (0.41) NPC1RAB9AHDAC8HDAC3HDAC4
SCHEMBL20787469 0.90 PLAU (0.40) PLAUHPNGAAMEN1KMT2A
SCHEMBL20788697 0.89 HDAC8 (0.34) NPC1RAB9AHDAC8HDAC3HDAC4
SCHEMBL20764599 0.88 CACNA1B (0.37) HDAC3HDAC1HDAC2PLAUHTT
SCHEMBL20764600 0.88 CACNA1B (0.37) HDAC3HDAC1HDAC2PLAUHTT
SCHEMBL20764482 0.87 MEN1 (0.44) NPC1RAB9AHDAC8HDAC3HDAC1
SCHEMBL22076698 0.87 MMP2 (0.38) NPC1HDAC3HDAC1HDAC2PLAU
SCHEMBL22076696 0.87 MMP2 (0.38) NPC1HDAC3HDAC1HDAC2PLAU
SCHEMBL20764481 0.87 MEN1 (0.44) NPC1RAB9AHDAC8HDAC3HDAC1
SCHEMBL20764477 0.86 MEN1 (0.37) NPC1RAB9AHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019038405-A1 NOVEL CYSTOBACTAMIDE DERIVATIVES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2019-02-28 — — WO disclosed
Send feedback